Intravenous steroids for ulcerative colitis

The overall remission (OR) rate (Complete Remission [CR] + CR in the absence of total platelet recovery [CRp]) was evaluated. CR was defined as no evidence of circulating blasts or extramedullary disease, an M1 bone marrow ( ≤ 5% blasts), and recovery of peripheral counts [platelets ≥ 100 x 10 9/ L and absolute neutrophil count (ANC) ≥ x 10 9/ L]. CRp was defined as meeting all criteria for CR except for recovery of platelet counts to ≥ 100 x 10 9/ L. Partial Response (PR) was also determined, defined as complete disappearance of circulating blasts, an M2 bone marrow ( ≥ 5% and ≤ 25% blasts), and appearance of normal progenitor cells or an M1 marrow that did not qualify for CR or CRp. Duration of remission was also evaluated. Transplantation rate was not a study endpoint.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.

Intravenous steroids for ulcerative colitis

intravenous steroids for ulcerative colitis

Media:

intravenous steroids for ulcerative colitisintravenous steroids for ulcerative colitisintravenous steroids for ulcerative colitisintravenous steroids for ulcerative colitisintravenous steroids for ulcerative colitis